Abstract
Novel pyrazole-based EZH2 inhibitors have been prepared through a molecular pruning approach from known inhibitors bearing a bicyclic moiety as a central scaffold. The hit compound 1o (N-((4,6-dimethyl-2-oxo-1,2-dihy-dropyridin-3-yl)methyl)-5-methyl-1-phenyl-1H-pyrazole-4-carboxamide) showed low micromolar EZH2/PRC2 inhibition and high selectivity towards a panel of other methyltransferases. Moreover, 1o displayed cell growth arrest in breast MDA-MB231, leukaemia K562, and neuroblastoma SK-N-BE cancer cells joined to reduction of H3K27me3 levels and induction of apoptosis and autophagy.
| Original language | English |
|---|---|
| Article number | 20170150 |
| Journal | Philosophical Transactions of the Royal Society B: Biological Sciences |
| Volume | 373 |
| Issue number | 1748 |
| DOIs | |
| State | Published - Jun 5 2018 |
| Externally published | Yes |
Keywords
- Apoptosis
- Autophagy
- Enhancer of zeste homologue 2 inhibitors
- Epigenetics
Fingerprint
Dive into the research topics of 'Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver